MEDIGUS LTD - SPON ADR (MDGS) Stock Price, Forecast & Analysis

NASDAQ:MDGS • US58471G4091

2.36 USD
+0.18 (+8.28%)
At close: Apr 17, 2024
2.6 USD
+0.24 (+10.17%)
After Hours: 4/17/2024, 8:12:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

MDGS Key Statistics, Chart & Performance

Key Statistics
Market Cap4.47M
Revenue(TTM)110.29M
Net Income(TTM)-13.27M
Shares1.89M
Float1.70M
52 Week High7.17
52 Week Low2.11
Yearly Dividend0.15
Dividend Yield29.82%
EPS(TTM)-6.98
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2006-02-27
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
MDGS short term performance overview.The bars show the price performance of MDGS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

MDGS long term performance overview.The bars show the price performance of MDGS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of MDGS is 2.36 USD. In the past month the price decreased by -13.24%. In the past year, price decreased by -55.13%.

MEDIGUS LTD - SPON ADR / MDGS Daily stock chart

MDGS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
MDGS Full Technical Analysis Report

MDGS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to MDGS. MDGS may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
MDGS Full Fundamental Analysis Report

MDGS Financial Highlights

Over the last trailing twelve months MDGS reported a non-GAAP Earnings per Share(EPS) of -6.98. The EPS decreased by -116% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -15.49%
ROE -41.78%
Debt/Equity 0.11
Chartmill High Growth Momentum
EPS Q2Q%-65%
Sales Q2Q%52.72%
EPS 1Y (TTM)-116%
Revenue 1Y (TTM)158.35%
MDGS financials

MDGS Forecast & Estimates

For the next year, analysts expect an EPS growth of 25.58% and a revenue growth 25.68% for MDGS


Analysts
Analysts82.86
Price TargetN/A
EPS Next Y25.58%
Revenue Next Year25.68%
MDGS Analyst EstimatesMDGS Analyst Ratings

MDGS Ownership

Ownership
Inst Owners0%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
MDGS Ownership

MDGS Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.65195.206B
ISRG INTUITIVE SURGICAL INC48.79175.203B
SYK STRYKER CORP24.68141.182B
BSX BOSTON SCIENTIFIC CORP21.66113.14B
BDX BECTON DICKINSON AND CO11.5150.537B
IDXX IDEXX LABORATORIES INC42.8150B
EW EDWARDS LIFESCIENCES CORP26.4245.525B
RMD RESMED INC20.9237.268B
GEHC GE HEALTHCARE TECHNOLOGY16.4437.194B
DXCM DEXCOM INC28.5527.469B

Related stock screener links

View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges

About MDGS

Company Profile

MDGS logo image Medigus Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm developed a range of micro video cameras underr micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD)

Company Info

MEDIGUS LTD - SPON ADR

10 HaNechoshet Street

TEL AVIV-YAFO IL

Employees: 77

MDGS Company Website

Phone: 972722602211

MEDIGUS LTD - SPON ADR / MDGS FAQ

What does MDGS do?

Medigus Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm developed a range of micro video cameras underr micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD)


Can you provide the latest stock price for MEDIGUS LTD - SPON ADR?

The current stock price of MDGS is 2.36 USD. The price increased by 8.28% in the last trading session.


Does MEDIGUS LTD - SPON ADR pay dividends?

MEDIGUS LTD - SPON ADR (MDGS) has a dividend yield of 29.82%. The yearly dividend amount is currently 0.15.


How is the ChartMill rating for MEDIGUS LTD - SPON ADR?

MDGS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.